Cardiology pp 551-560 | Cite as

Prevention of Catecholamine-Induced Myocardial Damage

  • A. Waldenström
  • A. Hjalmarson
  • B. Jacobsson

The improvement of prognosis of the acute myocardial infarction has mainly been due to detection and treatment of arrhythmias and congestive heart failure.


Acute Myocardial Infarction Myocardial Infarct Size Cardiotoxic Effect Succinylcholine Chloride Norwegian Multicenter Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Herlitz: Bedömning och begränsning av hjärtinfarktens storlek. En interventionsstudie med metoprolol. Thesis, Götenborg (1982).Google Scholar
  2. 2.
    J. I. Haft, P. D. Krantz, F. J. Albert and K. Fani: Intravascular platelet aggregation in the heart induced by norepinephrine. Microscopic studies. Circulation 46:698, (1972).PubMedCrossRefGoogle Scholar
  3. 3.
    O. Josué: Hypertrophie cardiaque causée par l’adiénaline et la toxine typhique. Cr Soc Bio (Paris) 63: 285, (1907).Google Scholar
  4. 4.
    K. Ziegler: über die Wirkung intravenöser Adrenalininjektion auf das Gefä β system und ihre Beziehung zur Arteriosklerose. Ziegler’s Bietrage 38:229 (1905).Google Scholar
  5. 5.
    W. Raab, R. van Lith, E. Lepeschkin and H. C. Herrlich: Catecholamine induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work. Am J Cardiol 9: 455, (1962).PubMedCrossRefGoogle Scholar
  6. 6.
    G. Rona, C. I. Chappel, T. Balazs and R. Gaudry: An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67: 443, (1959).Google Scholar
  7. 7.
    J. I. Haft: Cardiovascular injury induced by sympathetic catecholamines. Progr Cardiovasc Dis 17: 73, (1974).CrossRefGoogle Scholar
  8. 8.
    B. Ostádal, V. Rychterová and O. Poupa: Isoproterenol-induced acute experimental cardiac necrosis in the turtle (Testudo Horsfieldi) Am Heart J 76: 645–649, (1968).PubMedCrossRefGoogle Scholar
  9. 9.
    O. Poupa and A. Carlsten: Experimental cardiomyopathies in poikilotherms. In:” Recent Advances in Cardiac Structure and Metabolism, vol 2: Cardiomyopathies”. Eds : E. Bajusz and G. Rona. University Park Press, Baltimore 1973, pp.321–351.Google Scholar
  10. 10.
    P. R. Maroko and E. Braunwald: Effects of metabolic and pharmacologic interventions oil myocardial infarct size following coronary occlusion. Acta Med Scand, Suppl 587: 125–136 (1975).Google Scholar
  11. 11.
    P. R. Maroko, J. K. Kjekshus, B. E. Sobel, T. Watanabe, J. W. Covell, J. Ross Jr. and E. Braunwald: Factors influencing infarct size following experimental coronary artery occlusions. Circulations 43: 67, (1971).CrossRefGoogle Scholar
  12. 12.
    P. R. Maroko, P. Libby and E. Braunwald: Effect of pharmacologic agents on the function of the ischemic heart. Am J Cardiol 32: 930, (1973).PubMedCrossRefGoogle Scholar
  13. 13.
    I. Chapman: Relationships of recent coronary artery occlusion and acute myocardial infarction. J. Mt Sinai Hosp 35: 149, (1968).Google Scholar
  14. 14.
    C. J. Schwartz and J. R. A. Mitchell: The relation between myocardial lesions and coronary artery disease. 1: An unselected necropsy study. Br Heart J24: 761, (1962).CrossRefGoogle Scholar
  15. 15.
    D. Sinapius: Beziehungen zwischen Koronarthrombosen und Myokardinfarkten. Dtsch Med Wochenschr 97: 443, (1972).PubMedCrossRefGoogle Scholar
  16. 16.
    W. C. Roberts and L. M. Buja: The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. A study of 107 necropsy patients. Am J Med 52: 425, (1972).PubMedCrossRefGoogle Scholar
  17. 17.
    G. Baroldi: Acute coronary occlusion as a cause of myocardial infarction and suddet coronary heart death. Am J. Cardiol 16: 859, (1965).PubMedCrossRefGoogle Scholar
  18. 18.
    G. Baker, N. H. Zeller, S. Weitzner and J. K. Leach: Pheochromocytoma without hypertension presenting as cardiomyopathy. Am Heart J 83: 688–693 (1972).PubMedCrossRefGoogle Scholar
  19. 19.
    A. P. Waldenström, A. C. Hjalmarson and L. Thornell: A possible role of noradrenaline in the development of myocardial infarction. Am Heart J 95: 43–52, (1978).PubMedCrossRefGoogle Scholar
  20. 20.
    W. G. Nayler, R. Ferrari and A. M. Slade: Cardioprotective effect of calcium antagonists and beta-adrenergic blocking agents in myocardial ischaemia. In: “Calcium Antagonism in Cardiovascular Therapy. Experience with Verapamil”,Eds.: A. Zanchetti and D. M. Krikler, Exerpta Medica, Amsterdam-Oxford Princeton 1981, pp. 74–88.Google Scholar
  21. 21.
    K. I. Melville, B. Blum, H. E. Shister and M. D. Silver: Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation. Am J. Cardiol 12: 781–791, (1963).PubMedCrossRefGoogle Scholar
  22. 22.
    G. Johansson, K. Olsson, J. Häggendal, L. Jönsson and K. Thóren-Tolling: Effect of amygdalectomy of stress-induced myocardial necrosis and blood levels of catecholamines in pigs. Acta Physiol Scand 113: 553–555 (1981).PubMedCrossRefGoogle Scholar
  23. 23.
    G. Johansson, K. Olsson, J. Häggendal, L. Jönsson and K. Thóren-Tolling: Effect of stress on myocardial cells and blood levels of catecholamines in normal and amygdalectomized pigs. Can J Comp Med 46: 176–182, (1982).PubMedGoogle Scholar
  24. 24.
    J. Häggendal, G. Johansson, L. Jönsson and K. Thorén-Tolling: Effect of propranolol on myocardial cell necroses and blood levels of catecholamines in pigs subjected to stress. Acta Pharmacol et Toxicol 50: 58–66 (1982).CrossRefGoogle Scholar
  25. 25.
    A. Waldenström, B. Jacobsson and A. Hjalmarson: Heterogeneity of beta1- receptors in the rat heart. J Mol Cell Cardiol 13 Suppl 1: 97., 1981 (Abstra.).Google Scholar
  26. 26.
    A. Hjalmarson, D. Elmfeldt, J. Herlitz, S. Holmberg, I. Málek, G. Nyberg, L. Rydén, K. Swedberg, A. Vedin, F. Waagstein, A. Waldenström, J. Waldenström, H. Wedel, L. Wilhelmsen and C. Wilhelmsson: Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet ii: 823–828, (1981).CrossRefGoogle Scholar
  27. 27.
    The Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807, (1981).CrossRefGoogle Scholar
  28. 28.
    M. P. Andersen. P. Bechsgaard, J. Frederiksen. D. A. Hansen, H. J. Jürgensen, B. Nielsen. F. Pedersen. O. Pedersen-Bjergaard, S. L. Rasmussen: Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Lancet ii: 865–872, (1979).CrossRefGoogle Scholar
  29. 29.
    Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247: 1707–1714, (1982).CrossRefGoogle Scholar
  30. 30.
    J. Herlitz, A. Hjalmarson, K. Swedberg, F. Waagstein and A. Waldenström: A double-blind trial of metoprolol in acute myocardial infarction. Effect on infarct size, clinical findings and 1-year mortality. Abstr. (Am Heart Assoc, 55th Sessions). Circulation. In press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • A. Waldenström
    • 1
  • A. Hjalmarson
    • 1
  • B. Jacobsson
    • 1
  1. 1.Department of Medicine 1, Sahlgren’s HospitalUniversity of GöteborgGöteborgSweden

Personalised recommendations